ImmunityBio plans to hire 100 workers and begin manufacturing cancer treatments at the state-owned plant in Dunkirk by the ...
Updated terms call for ImmunityBio to initiate manufacturing at the Dunkirk plant by the end of 2028, at which point the ...
ImmunityBio (IBRX) stock falls as the FDA issues a warning letter regarding a TV commercial and a podcast related to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results